Skip to content

Expanding Fatty Acid Supplements Market Projected for Compound Annual Growth Rate (CAGR) of 7.5% Until 2034

The projection for the Fatty Acid Supplements Market predicts a value of approximately USD 12.6 billion by 2034, increasing from USD 6.1 billion in 2024, at a compound annual growth rate (CAGR) of 7.5%.

Expanding Fatty Acid Supplements Market Projected to Reach a Compound Annual Growth Rate (CAGR) of...
Expanding Fatty Acid Supplements Market Projected to Reach a Compound Annual Growth Rate (CAGR) of 7.5% by 2034

Expanding Fatty Acid Supplements Market Projected for Compound Annual Growth Rate (CAGR) of 7.5% Until 2034

In the health and wellness industry, the demand for fatty acid supplements, particularly those derived from marine sources like fish and krill oil, is on the rise. This surge in popularity is largely attributed to the benefits these supplements offer, particularly their high omega-3 content.

According to market research, the global fatty acid supplements marketplace is projected to grow significantly, with a Compound Annual Growth Rate (CAGR) of 7.5% from USD 6.1 billion in 2024 to USD 12.6 billion by 2034.

In 2024, the marketplace was dominated by Marine Oil, which held a 48.2% share. This dominance is not limited to the global marketplace, as North America, particularly the United States, plays a significant role in its dominance. The region accounted for a 32.6% revenue share in 2024.

The dietary supplements sector held a 38.4% market share in 2024, while supermarkets and hypermarkets captured a slightly larger share of 38.6%. The convenience factor, with the demand for formats like soft gels and gummies, and the wide variety of supplement brands, make these outlets favourable choices for consumers.

Notable companies in the marketplace include Glaxo Smith Kline plc, which divested its consumer healthcare division in 2024, forming a new independent company named Haleon. Another key player is DSM, which is innovating in algal omega-3s, targeting the dietary supplement and food fortification marketplaces.

Croda Health Care is also making significant strides, heavily investing in its Omega-3s for Life strategy, focusing on the commercialization of its new, highly concentrated and sustainable algal oil, Incromega DHA/EPA V. Arista Industries is another company expanding its GMO-free, plant-based omega offerings, including Ahiflower oil, which boasts a high SDA content for efficient conversion to EPA.

It's important to note that cardiovascular diseases remain the leading cause of death globally, according to the World Health Organization. As such, the demand for fatty acid supplements, which are known to support heart health, is expected to continue growing.

The global fatty acid supplements marketplace, excluding marine oil and dietary supplements, is valued at approximately USD 700 million in North America in 2024. This underscores the potential for growth and innovation in this sector.

In conclusion, the fatty acid supplements marketplace is a dynamic and growing industry, driven by consumer demand for omega-3 benefits and innovative products. With key players like Haleon, DSM, Croda Health Care, and Arista Industries, among others, investing in research and development, the future of this marketplace looks promising.

Read also:

Latest